Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Chromatin Immunoprecipitation Assay to Identify Genomic Binding Sites of Regulatory Factors.

Wagner M, Jung J, Koslowski M, Türeci Ö, Tiwari VK, Sahin U.

Methods Mol Biol. 2016;1366:53-65. doi: 10.1007/978-1-4939-3127-9_6.

PMID:
26585127
2.

Clinical imaging in anti-atherosclerosis drug development.

Ehlgen A, Bylock A, Kreuzer J, Koslowski M, Gantner F, Niessen HG.

Drug Discov Today. 2015 Nov;20(11):1317-27. doi: 10.1016/j.drudis.2015.06.014. Epub 2015 Jul 4. Review.

PMID:
26151479
3.

Engineering curvature in graphene ribbons using ultrathin polymer films.

Li C, Koslowski M, Strachan A.

Nano Lett. 2014 Dec 10;14(12):7085-9. doi: 10.1021/nl503527w. Epub 2014 Nov 10.

PMID:
25375290
4.

Nuclear imaging to support anti-inflammatory drug discovery and development.

Wunder A, Thiele A, Koslowski M, Gantner F, Niessen H.

Q J Nucl Med Mol Imaging. 2014 Sep;58(3):290-8. Review.

PMID:
25265250
5.

Nuclear imaging to support anti-inflammatory drug discovery and development.

Wunder A, Thiele A, Koslowski M, Gantner F, Niessen H.

Q J Nucl Med Mol Imaging. 2014 May 15. [Epub ahead of print]

PMID:
24829127
6.

NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.

Wagner M, Koslowski M, Paret C, Schmidt M, Türeci O, Sahin U.

BMC Cancer. 2013 Dec 4;13:570. doi: 10.1186/1471-2407-13-570.

7.

Confidence-based somatic mutation evaluation and prioritization.

Löwer M, Renard BY, de Graaf J, Wagner M, Paret C, Kneip C, Türeci O, Diken M, Britten C, Kreiter S, Koslowski M, Castle JC, Sahin U.

PLoS Comput Biol. 2012;8(9):e1002714. doi: 10.1371/journal.pcbi.1002714. Epub 2012 Sep 27.

8.

Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia.

Juckel G, Friedel E, Koslowski M, Witthaus H, Ozgürdal S, Gudlowski Y, Knutson B, Wrase J, Brüne M, Heinz A, Schlagenhauf F.

Neuropsychobiology. 2012;66(1):50-6. doi: 10.1159/000337130. Epub 2012 Jul 13.

PMID:
22797277
9.

Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease.

Koslowski MJ, Teltschik Z, Beisner J, Schaeffeler E, Wang G, Kübler I, Gersemann M, Cooney R, Jewell D, Reinisch W, Vermeire S, Rutgeerts P, Schwab M, Stange EF, Wehkamp J.

PLoS Genet. 2012;8(2):e1002523. doi: 10.1371/journal.pgen.1002523. Epub 2012 Feb 23.

10.

Exploiting the mutanome for tumor vaccination.

Castle JC, Kreiter S, Diekmann J, Löwer M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, Koslowski M, Kuhn AN, Britten CM, Huber C, Türeci O, Sahin U.

Cancer Res. 2012 Mar 1;72(5):1081-91. doi: 10.1158/0008-5472.CAN-11-3722. Epub 2012 Jan 11.

11.

Potassium-titanyl-phosphate laser vaporization of the prostate: a case series of an unusual complication.

Malde S, Rajagopalan A, Koslowski M, Simoes AD, Choi WH, Shrotri NC.

J Endourol. 2012 Jun;26(6):682-5. doi: 10.1089/end.2011.0493. Epub 2012 Feb 24.

PMID:
22204697
12.

A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer.

Reppert S, Boross I, Koslowski M, Türeci Ö, Koch S, Lehr HA, Finotto S.

Nat Commun. 2011 Dec 20;2:600. doi: 10.1038/ncomms1609.

PMID:
22186896
13.

FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines.

Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Hüsemann Y, Koslowski M, Huber C, Türeci Ö, Sahin U.

Cancer Res. 2011 Oct 1;71(19):6132-42. doi: 10.1158/0008-5472.CAN-11-0291. Epub 2011 Aug 4.

14.

Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals.

Türeci O, Koslowski M, Helftenbein G, Castle J, Rohde C, Dhaene K, Seitz G, Sahin U.

Gene. 2011 Aug 1;481(2):83-92. doi: 10.1016/j.gene.2011.04.007. Epub 2011 May 4.

PMID:
21571049
15.

Chorea in systemic lupus erythematosus.

Baizabal-Carvallo JF, Alonso-Juarez M, Koslowski M.

J Clin Rheumatol. 2011 Mar;17(2):69-72. doi: 10.1097/RHU.0b013e31820e7c8d.

PMID:
21325962
16.

Angiolymphoid hyperplasia with eosinophilia presenting as an axillary artery aneurysm.

Kukreja N, Koslowski M, Insall R.

BMJ Case Rep. 2011 May 3;2011. pii: bcr0220113836. doi: 10.1136/bcr.02.2011.3836.

17.

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

Kreiter S, Selmi A, Diken M, Koslowski M, Britten CM, Huber C, Türeci O, Sahin U.

Cancer Res. 2010 Nov 15;70(22):9031-40. doi: 10.1158/0008-5472.CAN-10-0699. Epub 2010 Nov 2.

18.

Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1α.

Koslowski M, Luxemburger U, Türeci O, Sahin U.

Oncogene. 2011 Feb 17;30(7):876-82. doi: 10.1038/onc.2010.481. Epub 2010 Nov 1.

PMID:
21042279
19.

Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells.

Gorr TA, Wichmann D, Pilarsky C, Theurillat JP, Fabrizius A, Laufs T, Bauer T, Koslowski M, Horn S, Burmester T, Hankeln T, Kristiansen G.

Acta Physiol (Oxf). 2011 Jul;202(3):563-81. doi: 10.1111/j.1748-1716.2010.02205.x. Epub 2010 Nov 12.

PMID:
20958924
20.

In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor.

Kurzik-Dumke U, Hörner M, Nicotra MR, Koslowski M, Natali PG.

J Transl Med. 2010 Jun 17;8:58. doi: 10.1186/1479-5876-8-58.

21.

Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease.

Perminow G, Beisner J, Koslowski M, Lyckander LG, Stange E, Vatn MH, Wehkamp J.

Am J Gastroenterol. 2010 Feb;105(2):452-9. doi: 10.1038/ajg.2009.643. Epub 2009 Nov 10.

PMID:
19904243
22.

Innate antimicrobial host defense in small intestinal Crohn's disease.

Koslowski MJ, Beisner J, Stange EF, Wehkamp J.

Int J Med Microbiol. 2010 Jan;300(1):34-40. doi: 10.1016/j.ijmm.2009.08.011. Epub 2009 Oct 21. Review.

PMID:
19850516
23.

A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa.

Kotarsky K, Sitnik KM, Stenstad H, Kotarsky H, Schmidtchen A, Koslowski M, Wehkamp J, Agace WW.

Mucosal Immunol. 2010 Jan;3(1):40-8. doi: 10.1038/mi.2009.115. Epub 2009 Oct 7.

PMID:
19812544
24.

Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2.

Koslowski M, Türeci O, Huber C, Sahin U.

Mol Cancer. 2009 Sep 25;8:77. doi: 10.1186/1476-4598-8-77.

25.

Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2.

Koslowski M, Türeci O, Biesterfeld S, Seitz G, Huber C, Sahin U.

J Biol Chem. 2009 Oct 16;284(42):28607-15. doi: 10.1074/jbc.M109.031120. Epub 2009 Aug 3.

26.

Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's disease.

Kübler I, Koslowski MJ, Gersemann M, Fellermann K, Beisner J, Becker S, Rothfuss K, Herrlinger KR, Stange EF, Wehkamp J.

Aliment Pharmacol Ther. 2009 Sep 15;30(6):621-33. doi: 10.1111/j.1365-2036.2009.04070.x. Epub 2009 Jun 22.

27.

A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.

Maxeiner JH, Karwot R, Sauer K, Scholtes P, Boross I, Koslowski M, Türeci O, Wiewrodt R, Neurath MF, Lehr HA, Finotto S.

Cancer Res. 2009 Apr 1;69(7):3069-76. doi: 10.1158/0008-5472.CAN-08-1678. Epub 2009 Mar 24.

28.

Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.

Gersemann M, Becker S, Kübler I, Koslowski M, Wang G, Herrlinger KR, Griger J, Fritz P, Fellermann K, Schwab M, Wehkamp J, Stange EF.

Differentiation. 2009 Jan;77(1):84-94. doi: 10.1016/j.diff.2008.09.008. Epub 2008 Oct 22.

PMID:
19281767
29.

Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.

Koslowski MJ, Kübler I, Chamaillard M, Schaeffeler E, Reinisch W, Wang G, Beisner J, Teml A, Peyrin-Biroulet L, Winter S, Herrlinger KR, Rutgeerts P, Vermeire S, Cooney R, Fellermann K, Jewell D, Bevins CL, Schwab M, Stange EF, Wehkamp J.

PLoS One. 2009;4(2):e4496. doi: 10.1371/journal.pone.0004496. Epub 2009 Feb 16.

30.

Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease.

Wehkamp J, Koslowski M, Wang G, Stange EF.

Mucosal Immunol. 2008 Nov;1 Suppl 1:S67-74. doi: 10.1038/mi.2008.48. Review.

PMID:
19079235
31.

Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.

Sahin U, Koslowski M, Dhaene K, Usener D, Brandenburg G, Seitz G, Huber C, Türeci O.

Clin Cancer Res. 2008 Dec 1;14(23):7624-34. doi: 10.1158/1078-0432.CCR-08-1547.

32.

Antimicrobial host defense in the upper gastrointestinal tract.

Hosaka Y, Koslowski M, Nuding S, Wang G, Schlee M, Schäfer C, Saigenji K, Stange EF, Wehkamp J.

Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1151-8. doi: 10.1097/MEG.0b013e3283052ddb.

PMID:
18989140
33.

Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia.

Ballmaier M, Schlagenhauf F, Toga AW, Gallinat J, Koslowski M, Zoli M, Hojatkashani C, Narr KL, Heinz A.

Schizophr Res. 2008 Dec;106(2-3):140-7. doi: 10.1016/j.schres.2008.08.025. Epub 2008 Sep 24.

34.

Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory.

Schlagenhauf F, Wüstenberg T, Schmack K, Dinges M, Wrase J, Koslowski M, Kienast T, Bauer M, Gallinat J, Juckel G, Heinz A.

Eur Neuropsychopharmacol. 2008 Aug;18(8):589-99. doi: 10.1016/j.euroneuro.2008.04.013. Epub 2008 Jun 12.

PMID:
18554874
35.

MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.

Koslowski M, Sahin U, Dhaene K, Huber C, Türeci O.

Cancer Res. 2008 May 1;68(9):3458-66. doi: 10.1158/0008-5472.CAN-07-5768. Erratum in: Cancer Res. 2008 Jun 15;68(12):4958.

36.

In silico strategy for detection of target candidates for antibody therapy of solid tumors.

Helftenbein G, Koslowski M, Dhaene K, Seitz G, Sahin U, Türeci O.

Gene. 2008 May 15;414(1-2):76-84. doi: 10.1016/j.gene.2008.02.009. Epub 2008 Feb 19.

PMID:
18358640
37.

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.

Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A.

Psychopharmacology (Berl). 2008 Mar;196(4):673-84. Epub 2007 Dec 21.

PMID:
18097655
38.

Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.

Kurzik-Dumke U, Hörner M, Czaja J, Nicotra MR, Simiantonaki N, Koslowski M, Natali PG.

Int J Mol Med. 2008 Jan;21(1):19-31.

PMID:
18097612
39.

A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.

Koslowski M, Sahin U, Mitnacht-Kraus R, Seitz G, Huber C, Türeci O.

Cancer Res. 2007 Oct 1;67(19):9528-34.

40.

Identification of new claudin family members by a novel PSI-BLAST based approach with enhanced specificity.

Wu J, Helftenbein G, Koslowski M, Sahin U, Tureci O.

Proteins. 2006 Dec 1;65(4):808-15.

PMID:
17022085
41.

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, Türeci O, Sahin U.

Blood. 2006 Dec 15;108(13):4009-17. Epub 2006 Aug 29.

PMID:
16940422
42.

The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes.

Koslowski M, Sahin U, Huber C, Türeci O.

Hum Mol Genet. 2006 Aug 1;15(15):2392-9. Epub 2006 Jun 29.

PMID:
16809397
43.

Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.

Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wüstenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A.

Psychopharmacology (Berl). 2006 Aug;187(2):222-8. Epub 2006 May 24.

PMID:
16721614
44.

Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer.

Grunwald C, Koslowski M, Arsiray T, Dhaene K, Praet M, Victor A, Morresi-Hauf A, Lindner M, Passlick B, Lehr HA, Schäfer SC, Seitz G, Huber C, Sahin U, Türeci O.

Int J Cancer. 2006 May 15;118(10):2522-8.

45.

Dysfunction of ventral striatal reward prediction in schizophrenia.

Juckel G, Schlagenhauf F, Koslowski M, Wüstenberg T, Villringer A, Knutson B, Wrase J, Heinz A.

Neuroimage. 2006 Jan 15;29(2):409-16. Epub 2005 Sep 1.

PMID:
16139525
46.

Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature.

Dhar KK, NeedhiRajan T, Koslowski M, Woolas RP.

Gynecol Oncol. 2005 Jun;97(3):924-7. Review.

PMID:
15943993
47.

Dislocation structures and the deformation of materials.

Koslowski M, Lesar R, Thomson R.

Phys Rev Lett. 2004 Dec 31;93(26 Pt 1):265503. Epub 2004 Dec 27.

PMID:
15697990
48.

Avalanches and scaling in plastic deformation.

Koslowski M, LeSar R, Thomson R.

Phys Rev Lett. 2004 Sep 17;93(12):125502. Epub 2004 Sep 14.

PMID:
15447275
49.

Frequent nonrandom activation of germ-line genes in human cancer.

Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Müntefering H, Huber C, Sahin U, Türeci O.

Cancer Res. 2004 Sep 1;64(17):5988-93.

50.

Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA).

Taguchi Y, Koslowski M, Bodenner DL.

Nucl Recept. 2004 Aug 19;2(1):5.

Supplemental Content

Loading ...
Support Center